Actively Recruiting
Longitudinal Registry Including Patients Treated With Heavy Particles
Led by CNAO National Center of Oncological Hadrontherapy · Updated on 2025-08-06
3000
Participants Needed
1
Research Sites
2608 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia. By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.
CONDITIONS
Official Title
Longitudinal Registry Including Patients Treated With Heavy Particles
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients treated with heavy particles at Fondazione CNAO, Pavia
- Patients who have the ability to understand and be willing to sign a written informed consent document
You will not qualify if you...
- Patients or legal guardians who are unable to understand informed consent document
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Center for Oncological Hadrontherapy (CNAO)
Pavia, Italy, 27100
Actively Recruiting
Research Team
C
Chiara Campo, PhD
CONTACT
C
Cristina Bono
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here